Literature DB >> 23523566

Transcriptional activity of c-Jun is critical for the suppression of AR function.

Chih-Chao Hsu1, Chang-Deng Hu.   

Abstract

Androgen receptor (AR) signaling plays a pivotal role in growth and survival of prostate cancer cells. c-Jun is an important member of the activator protein 1 (AP-1) family and was shown to interact with AR. However, the role of c-Jun in AR signaling remains controversial, with being a coactivator or a corepressor reported. Here, utilizing multiple approaches, we show that c-Jun efficiently inhibits AR activity and the growth of prostate cancer cells. Overexpression of c-Jun inhibits not only the activities of various androgen-responsive promoters but also the transcripts of multiple AR target genes. Interestingly, long-term c-Jun overexpression also down-regulates AR expression at both the protein and mRNA levels. Molecular analysis suggests that c-Jun inhibits AR transactivation potential via an unknown target gene. The inhibition of AR by c-Jun occurs in both hormone naïve and castration-resistant prostate cancer cells. Our results unravel a novel mechanism by which c-Jun antagonizes the AR signaling.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523566      PMCID: PMC3646949          DOI: 10.1016/j.mce.2013.03.004

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  68 in total

1.  Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potencies.

Authors:  P H Brown; S H Kim; S C Wise; A L Sabichi; M J Birrer
Journal:  Cell Growth Differ       Date:  1996-08

2.  Transcriptional interferences between normal or mutant androgen receptors and the activator protein 1--dissection of the androgen receptor functional domains.

Authors:  J M Lobaccaro; N Poujol; B Térouanne; V Georget; S Fabre; S Lumbroso; C Sultan
Journal:  Endocrinology       Date:  1999-01       Impact factor: 4.736

3.  Identification of domains of c-Jun mediating androgen receptor transactivation.

Authors:  S C Wise; L A Burmeister; X F Zhou; A Bubulya; J L Oberfield; M J Birrer; L Shemshedini
Journal:  Oncogene       Date:  1998-04-16       Impact factor: 9.867

4.  Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP.

Authors:  N Sato; M D Sadar; N Bruchovsky; F Saatcioglu; P S Rennie; S Sato; P H Lange; M E Gleave
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

5.  Differential gene expression of steroid 5 alpha-reductase 2 in core needle biopsies from malignant and benign prostatic tissue.

Authors:  C Bjelfman; T G Söderström; E Brekkan; B J Norlén; L Egevad; T Unge; S Andersson; A Rane
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

6.  Effects of Ca++ mobilization on expression of androgen-regulated genes: interference with androgen receptor-mediated transactivation by AP-I proteins.

Authors:  P E Murtha; W Zhu; J Zhang; S Zhang; C Y Young
Journal:  Prostate       Date:  1997-12-01       Impact factor: 4.104

7.  CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1.

Authors:  K Frønsdal; N Engedal; T Slagsvold; F Saatcioglu
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

8.  Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions.

Authors:  C Albanese; J Johnson; G Watanabe; N Eklund; D Vu; A Arnold; R G Pestell
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

9.  Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro.

Authors:  A J Bannister; T Oehler; D Wilhelm; P Angel; T Kouzarides
Journal:  Oncogene       Date:  1995-12-21       Impact factor: 9.867

10.  c-Jun can mediate androgen receptor-induced transactivation.

Authors:  A Bubulya; S C Wise; X Q Shen; L A Burmeister; L Shemshedini
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

View more
  13 in total

1.  Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.

Authors:  Bethtrice Elliott; Ana Cecilia Millena; Lilya Matyunina; Mengnan Zhang; Jin Zou; Guangdi Wang; Qiang Zhang; Nathan Bowen; Vanessa Eaton; Gabrielle Webb; Shadyra Thompson; John McDonald; Shafiq Khan
Journal:  Cancer Lett       Date:  2019-02-11       Impact factor: 8.679

2.  A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.

Authors:  Eswar Shankar; Kyung Song; Sarah L Corum; Kara L Bane; Hui Wang; Hung-Ying Kao; David Danielpour
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

3.  Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells.

Authors:  Christopher D Suarez; Xuehong Deng; Chang-Deng Hu
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

Review 4.  Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.

Authors:  Jeroen Kneppers; Andries M Bergman; Wilbert Zwart
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer.

Authors:  Renee E Vickman; Scott A Crist; Kevin Kerian; Livia Eberlin; R Graham Cooks; Grant N Burcham; Kimberly K Buhman; Chang-Deng Hu; Andrew D Mesecar; Liang Cheng; Timothy L Ratliff
Journal:  Mol Cancer Res       Date:  2016-06-24       Impact factor: 5.852

6.  Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells.

Authors:  Huan-Tian Zhang; Dabao Zhang; Zhen-Gang Zha; Chang-Deng Hu
Journal:  Biochim Biophys Acta       Date:  2014-10-02

7.  Lysine-specific demethylase 1 mediates epidermal growth factor signaling to promote cell migration in ovarian cancer cells.

Authors:  Genbao Shao; Jie Wang; Yuanxia Li; Xiuwen Liu; Xiaodong Xie; Xiaolei Wan; Meina Yan; Jie Jin; Qiong Lin; Haitao Zhu; Liuping Zhang; Aihua Gong; Qixiang Shao; Chaoyang Wu
Journal:  Sci Rep       Date:  2015-10-22       Impact factor: 4.379

8.  Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.

Authors:  X Deng; G Shao; H-T Zhang; C Li; D Zhang; L Cheng; B D Elzey; R Pili; T L Ratliff; J Huang; C-D Hu
Journal:  Oncogene       Date:  2016-08-22       Impact factor: 9.867

9.  The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis.

Authors:  Megan Crumbaker; Eva K F Chan; Tingting Gong; Niall Corcoran; Weerachai Jaratlerdsiri; Ruth J Lyons; Anne-Maree Haynes; Anna A Kulidjian; Anton M F Kalsbeek; Desiree C Petersen; Phillip D Stricker; Christina A M Jamieson; Peter I Croucher; Christopher M Hovens; Anthony M Joshua; Vanessa M Hayes
Journal:  Cancers (Basel)       Date:  2020-05-07       Impact factor: 6.639

10.  Factors that influence the androgen receptor cistrome in benign and malignant prostate cells.

Authors:  Ben T Copeland; Juan Du; Sumanta K Pal; Jeremy O Jones
Journal:  Mol Oncol       Date:  2019-10-13       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.